Qtron Investments’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Qtron Investments's ELV Position: Q2 2026 in Review
Qtron Investments increased its Elevance Health (ELV) stake by 72% in Q2 2026, buying an estimated $248K and bringing the position to 1,592 shares worth $616K. The position accounts for 0.08% of the portfolio, ranked #284.
Qtron Investments first reported a position in ELV in Q2 2020 and has held it in 25 quarters since. The position peaked at $2.03M in Q4 2021. 1,609 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Qtron Investments held 1,592 shares of Elevance Health worth $616K as of Q2 2026.
- Qtron Investments bought 668 Elevance Health shares in Q2 2026, an estimated $248K.
- Elevance Health made up 0.08% of Qtron Investments's portfolio in Q2 2026, its #284 holding.
- Qtron Investments first reported a position in Elevance Health in Q2 2020 and has held it in 25 quarters since.
- Qtron Investments's Elevance Health position peaked at $2.03M in Q4 2021.
- 1,609 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Qtron Investments's 13F filing for Q2 2026, filed 13 Aug 2026.